Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.540
-0.050 (-3.14%)
At close: Aug 13, 2025, 4:00 PM
1.550
+0.010 (0.65%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Pulmonx Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$311,165
Profits / Employee
-$195,670
Market Cap
62.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LUNG News
- 14 days ago - Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Pulmonx Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - GlobeNewsWire
- 2 months ago - Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 3 months ago - Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pulmonx Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire